Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company’s pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; BHV-7010, a Kv7 channel modulator for the treatment of different neurological diseases.
Read MoreCorVel Corporation (CRVL) CorVel Corporation provides workers’ compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies. Bowman Consulting Group Ltd. (BWMN) Bowman Consulting Group Ltd. provides a range of real estate, energy, infrastructure, and environmental management solutions in the United States. It offers civil and site engineering services, […]
Read MoreMarket conditions are Bullish in a Bull Market as of 2023-12-20. This means traders and investors should consider trading with a Bullish bias by buying (going long) stocks, long ETF’s or Call Options. The rank of the Bull Market is 13.27 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read More